Site içinde arama yapın

Ved Fma bir ses eklendi Health
2025-06-25 11:18:48 -

Bevacizumab Biosimilar: Global Market Trends and Insights 2025-2033
The Bevacizumab Biosimilar Market is on the rise, driven by a surge in global cancer cases and an increasing demand for affordable biologic treatments. With the original Avastin patent now expired, innovative biosimilars like Mvasi, Zirabev, and Abevmy are emerging as key players, making significant waves, particularly in the oncology sector. Healthcare systems are seizing the opportunity to...

0 Yorumlar 0 hisse senetleri 407 Views 0 önizleme

Please log in to like, share and comment!
Harsh Jaiswalharsh9090 bir ses eklendi Literature
2025-07-29 10:45:40 -

Biosimilar and Biologics Market : Size, Trends, and Growth Analysis 2032
The Biosimilar and Biologics Market is undergoing a seismic shift as demand for affordable, effective treatments continues to surge worldwide. With innovations in biotechnology, growing cases of chronic and autoimmune diseases, and the looming expiration of several high-profile biologic drug patents, both biologics and their biosimilar counterparts are redefining how modern medicine is...

0 Yorumlar 0 hisse senetleri 209 Views 0 önizleme

Please log in to like, share and comment!
Ved Fma bir ses eklendi Health
2025-07-09 07:32:01 -

Biosimilar Growth Hormones Market: Revolutionizing Hormone Therapy 2025-2033
According to FutureWise analysis the market for biosimilar growth hormones is expected to register a CAGR of 8.62% from 2025-2033. A biosimilar, often referred to as a follow-on biologic or subsequent entry biologic, represents a significant advancement in the pharmaceutical industry. Think of it as a cousin to an original biological product, crafted by a different company once the patent on...

0 Yorumlar 0 hisse senetleri 278 Views 0 önizleme

Please log in to like, share and comment!
Ved Fma bir ses eklendi Health
2025-07-09 07:39:27 -

Biosimilar Interleukins Market: Regional Insights 2025-2033
According to FutureWise analysis the market for biosimilar interleukins in 2023 is US$ 2.83 billion, and is expected to reach US$ 44.48 billion by 2031 at a CAGR of 41.10%. The global market for Biosimilar Interleukin is on an exciting upward trajectory, poised for explosive growth. Starting at approximately USD 3.9 billion in 2023, it’s set to leap to USD 5.41 billion by 2024 and is...

0 Yorumlar 0 hisse senetleri 276 Views 0 önizleme

Please log in to like, share and comment!
Amol Shinde bir ses eklendi Health
2025-05-05 07:03:31 -

Biosimilar Market Poised for Growth, Projected to Reach $125.32 Billion by 2034
Biosimilar Market Overview 2024-2034 Biosimilar Market Growth is expected to grow at a compound annual growth rate (CAGR) of 18.32% between 2024 and 2034, reaching an estimated value of USD 125.32 billion by the end of the forecast period. In 2024, the market is projected to be valued at USD 27.46 billion. What Are Biosimilars? Biosimilars are highly similar, safe, and effective...

0 Yorumlar 0 hisse senetleri 615 Views 0 önizleme

Please log in to like, share and comment!
Rucha Pathak bir ses eklendi Other
2025-06-02 06:14:56 -

Monoclonal Antibodies Market Companies: Growth, Share, Value, Analysis, and Trends
"Global Monoclonal Antibodies Market Size, Share, and Trends Analysis Report—Industry Overview and Forecast to 2032 Executive Summary: Global monoclonal antibodies market size was valued at USD 263.22 billion in 2024 and is projected to reach USD 719.81 billion by 2032, with a CAGR of 13.40% during the forecast period of 2025 to 2032. Monoclonal Antibodies...

0 Yorumlar 0 hisse senetleri 642 Views 0 önizleme

Please log in to like, share and comment!
Priti More bir ses eklendi Other
2025-05-28 03:32:57 -

Monoclonal Antibodies Market Insights: Growth, Share, Value, Size, and Analysis
" Global Monoclonal Antibodies Market Size, Share, and Trends Analysis Report—Industry Overview and Forecast to 2032 Executive Summary: Global monoclonal antibodies market size was valued at USD 263.22 billion in 2024 and is projected to reach USD 719.81 billion by 2032, with a CAGR of 13.40% during the forecast period of 2025 to 2032. Global Monoclonal Antibodies...

0 Yorumlar 0 hisse senetleri 662 Views 0 önizleme

Please log in to like, share and comment!